Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) Receivables - Other (2020 - 2023)

AVITA Medical filings provide 4 years of Receivables - Other readings, the most recent being $30000.0 for Q4 2023.

  • On a quarterly basis, Receivables - Other fell 96.66% to $30000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $30000.0, a 96.66% decrease, with the full-year FY2023 number at $30000.0, down 96.66% from a year prior.
  • Receivables - Other hit $30000.0 in Q4 2023 for AVITA Medical, down from $442000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $3.9 million in Q2 2021 to a low of $30000.0 in Q4 2023.
  • Median Receivables - Other over the past 4 years was $516000.0 (2023), compared with a mean of $968538.5.
  • Biggest five-year swings in Receivables - Other: surged 1005.62% in 2021 and later crashed 96.66% in 2023.
  • AVITA Medical's Receivables - Other stood at $440000.0 in 2020, then decreased by 30.0% to $308000.0 in 2021, then surged by 191.56% to $898000.0 in 2022, then crashed by 96.66% to $30000.0 in 2023.
  • The last three reported values for Receivables - Other were $30000.0 (Q4 2023), $442000.0 (Q2 2023), and $516000.0 (Q1 2023) per Business Quant data.